Search The Medical Knowledge Base

Medical News by Date

• Erivedge (Genentech/Roche)is FDA approved for Basal Cell Carcinoma
  

  Published: Tuesday 31 January 2012

• FDA approves Jentadueta(Boehringer/Eli Lilly) for Type 2 Diabetes
  

  Published: Tuesday 31 January 2012

• Varisolve (BTG) success in VANISH-2 trial for Varicose Vein treatment
  

  Published: Tuesday 31 January 2012

• FDA approves Kalydeco (Vertex Pharma) for Cystic Fibrosis
  

  Published: Tuesday 31 January 2012

• FDA approves wider indication for fibrin sealant Tisseel (Baxter)
  

  Published: Monday 30 January 2012

• Pfizer files bosutinib at FDA for PH+CML
  

  Published: Sunday 29 January 2012

• Tysabri(Biogen IDEC/Elan) enters Phase III ASCEND trial for Secondary Progressive Multiple Sclerosis
  

  Published: Sunday 29 January 2012

• FDA approves Inlyta (Pfizer) for Renal Cell Carcinoma
  

  Published: Saturday 28 January 2012

• Afatinib(Boehringer) enters Phase III trials for Head and Neck Cancer
  

  Published: Saturday 28 January 2012

• OraQuick Advance Rapid HIV-112 (OraSure) compares to conventional blood test for HIV
  

  Published: Friday 27 January 2012

• Spectrum Pharma acquires world rights to Zevalin for NHL
  

  Published: Friday 27 January 2012

• CHMP recommends Remicade (Janssen Biologic) for Paediatric Ulcerative Colitis
  

  Published: Thursday 26 January 2012

• Picato (Leo Pharma) is FDA approved for Actinic Keratosis
  

  Published: Thursday 26 January 2012

• Afinitor (Novartis) fails Gastric Cancer study
  

  Published: Thursday 26 January 2012

• Rebif (Merck Serono) is EU approved for Early Multiple Sclerosis
  

  Published: Thursday 26 January 2012

• Ipsen returns ROW rights to fipamezole to Santhera Pharma
  

  Published: Wednesday 25 January 2012

• Eloxatin (Sanofi) improves Colon Cancer survival
  

  Published: Wednesday 25 January 2012

• CHMP rejects Folotyn (AllosTherapeutics and Mundipharma) for T-Cell Lymphoma
  

  Published: Wednesday 25 January 2012

• NICE final guidance positive for Eliquis(BMS/Pfizer)in VTE
  

  Published: Wednesday 25 January 2012

• Gammagard Liquid10% (Baxter) in second Alzheimers Disease Phase III trial
  

  Published: Tuesday 24 January 2012

• Aganocide (Novabay Pharma) enters Phase IIb trial for Adenoviral Conjunctivitis
  

  Published: Tuesday 24 January 2012

• FDA label change for Tysabri (Biogen IDEC) for Multiple Sclerosis and approval of JCV antibody test
  

  Published: Sunday 22 January 2012

• New FDA drug labels for anaemia associated with Chronic Kidney Disease patients treated with ESAs
  

  Published: Sunday 22 January 2012

• CHMP recommends Signifor (Novartis) for treatment of Cushing's Disease
  

  Published: Saturday 21 January 2012

• Gilenya(Novartis) patients with Multiple Sclerosis to be monitored after first dosing
  

  Published: Saturday 21 January 2012

• Novel antibacterial ozenoxacin (Ferrer) enters Phase III for treatment for Impetigo
  

  Published: Saturday 21 January 2012

• Positive results for 4CMenB (Novartis) vaccine against group B Meningococcal Disease
  

  Published: Friday 20 January 2012

• FDA issues Complete Response Letter for dapagliflozin (AstraZeneca/BMS) for Type 2 Diabetes
  

  Published: Thursday 19 January 2012

• Daclatasvir plus asunaprevir(BMS) in Phase II Hepatitis C trial
  

  Published: Thursday 19 January 2012

• Inferanserin (Ventrus BioSciences) in Phase III for treatment of Haemorrhoids
  

  Published: Wednesday 18 January 2012

• Cangrelor (AstraZeneca/ The Medicines Company) maintains platelet inhibition and anti-clotting levels prior to Cardiac Surgery
  

  Published: Wednesday 18 January 2012

• Bayer HealthCare plans to file regorafenib at the FDA for Metastatic Colorectal Cancer in 2012
  

  Published: Wednesday 18 January 2012

• Epic Nitinol Stent success in ORION trial for Iliac Artery Disease
  

  Published: Wednesday 18 January 2012

• Combining 2 anti-HER2 drugs may provide better preoperative breast cancer treatment
  

  Published: Wednesday 18 January 2012

• Combination treatment with Tekturna/Rasilez (Novartis) raises risk for patients with Hypertension
  

  Published: Tuesday 17 January 2012

• Sycrest(Lundbeck) is launched for Bipolar Disorder in UK
  

  Published: Monday 16 January 2012

• New device is FDA filed by Genentech to extend period of release of Lucentis
  

  Published: Monday 16 January 2012

• Stenting with Emboshield Pro (Abbott Vascular) for Carotid Arteryt Disease becoming safer in high-risk patients
  

  Published: Sunday 15 January 2012

• FDA extends Berinert (CSL Behring) indication to self administration in HAE attacks
  

  Published: Saturday 14 January 2012

• Pradaxa(Boehringer) risk of Myocardial Infarction and Acute Coronary Syndrome
  

  Published: Friday 13 January 2012

• Intuniv (Shire) shows positive response for children with ADHD
  

  Published: Friday 13 January 2012

• GLP-1R Agonists lead to weight loss in overweight or obese patients
  

  Published: Friday 13 January 2012

• Isentress (Merck) shows promise in treating young patients with HIV
  

  Published: Friday 13 January 2012

• BioDelivery Sciences Intl licenses BEMA buprenorphine to Endo Pharma for mild to severe Chronic Pain
  

  Published: Thursday 12 January 2012

• Tradjenta (Boehringer) shows no added benefit in assessment for Type 2 Diabetes
  

  Published: Wednesday 11 January 2012

• Zytiga (J&J Janssen Cilag) offers benefits for Prostate Cancer patients who are not eligible for docetaxel therapy
  

  Published: Wednesday 11 January 2012

• Nexavar (Bayer HealthCare) effective in patients with Non-Small Cell Lung Cancer
  

  Published: Wednesday 11 January 2012

• FDA approves Anturol (Watson Pharma) for Overactive Bladder treatment
  

  Published: Monday 02 January 2012

• FDA approves Chocolate PTA Balloon Catheter(TriReme Medical) for PAD
  

  Published: Monday 02 January 2012

• Xarelto (Bayer/Janssen) is FDA filed for Acute Coronary Syndrome
  

  Published: Monday 02 January 2012